Kidney cancer PDOXs reveal patient‐specific pro‐malignant effects of antiangiogenics and its molecular traits

An open debate in antiangiogenic therapies is about their consequence on tumor invasiveness and metastasis, which is undoubtedly relevant for patients currently treated with antiangiogenics, such as renal cell carcinoma patients. To address, this we developed an extensive series of 27 patient biopsy...

Descripción completa

Detalles Bibliográficos
Autores principales: Moserle, Lidia, Pons, Roser, Martínez‐Lozano, Mar, Jiménez‐Valerio, Gabriela A, Vidal, August, Suárez, Cristina, Trilla, Enrique, Jiménez, José, de Torres, Inés, Carles, Joan, Senserrich, Jordi, Aguilar, Susana, Palomero, Luis, Amadori, Alberto, Casanovas, Oriol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721359/
https://www.ncbi.nlm.nih.gov/pubmed/33151035
http://dx.doi.org/10.15252/emmm.201911889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721359/
https://www.ncbi.nlm.nih.gov/pubmed/33151035
http://dx.doi.org/10.15252/emmm.201911889

Ejemplares similares